Latest news with #Altria
Forbes
17 hours ago
- Business
- Forbes
How Will Altria Stock React To Its Upcoming Earnings?
CHONGQING, CHINA - JULY 28: In this photo illustration, a person holds a smartphone displaying the ... More logo of Altria Group Inc. (NYSE: MO), one of the largest tobacco and nicotine product manufacturers in the United States, with a colorful mosaic background featuring the company's brand identity, on July 28, 2025 in Chongqing, China. (Photo illustration by) Altria (NYSE:MO) is set to announce its earnings on Wednesday, July 30, 2025. For traders focused on events, gaining insight into historical stock performance during earnings periods can offer a significant advantage, although the actual outcomes versus consensus estimates will primarily influence market reactions. In the past five years, Altria's stock has delivered a positive one-day return in 53% of the cases following earnings announcements. When the returns were positive, the median one-day increase was 1.9%, with the highest one-day increase reaching 7.8%. Two key strategies to consider include: Analysts project that Altria will report earnings of $1.38 per share on revenues of $5.19 billion. This is in comparison to the same quarter last year, during which Altria reported earnings of $1.31 per share on revenue of $5.28 billion. From a fundamental standpoint, Altria has a current market capitalization of $101 billion. In the past twelve months, the company generated $20 billion in revenue, with $12 billion in operating profits and a net income of $10 billion, indicating robust operational profitability. Nonetheless, if you are looking for growth with less volatility compared to individual stocks, the Trefis High Quality portfolio offers an alternative—it has outperformed the S&P 500 and produced returns greater than 91% since its launch. Also, check out – Time To Buy Centene Stock? See earnings reaction history of all stocks Altria's Historical Odds Of Positive Post-Earnings Return Here are some insights on one-day (1D) post-earnings returns: Additional information regarding observed 5-Day (5D) and 21-Day (21D) returns following earnings is included along with the statistics in the table below. MO 1D, 5D, and 21D Post Earnings Return Correlation Between 1D, 5D, and 21D Historical Returns A relatively less risky approach (although it may not be beneficial if the correlation is weak) is to grasp the correlation between short-term and medium-term returns following earnings, identify the pair with the highest correlation, and execute the suitable trade. For instance, if 1D and 5D demonstrate the highest correlation, a trader can adopt a "long" position for the next 5 days if the 1D post-earnings return is favorable. Below is some correlation data based on 5-year and 3-year (more recent) history. Note that the correlation 1D_5D refers to the correlation between 1D post-earnings returns and subsequent 5D returns. MO Correlation Between 1D, 5D and 21D Historical Returns Is There Any Correlation With Peer Earnings? Occasionally, the performance of peers can impact post-earnings stock reactions. In fact, the pricing might start prior to the earnings announcement. Below is some historical data comparing the past post-earnings performance of Altria stock with the performance of peers that reported earnings just before Altria. For a fair comparison, peer stock returns also reflect post-earnings one-day (1D) returns. MO Correlation With Peer Earnings Discover more about Trefis RV strategy that has outperformed its all-cap stocks benchmark (combination of the S&P 500, S&P mid-cap, and Russell 2000), producing strong returns for its investors. Additionally, if you're looking for growth with a less turbulent experience than investing in a single stock like Altria, consider the High Quality portfolio, which has surpassed the S&P and yielded >91% returns since its inception.
Yahoo
a day ago
- Business
- Yahoo
Altria (MO) Reports Q2: Everything You Need To Know Ahead Of Earnings
Tobacco company Altria (NYSE:MO) will be reporting results this Wednesday before market hours. Here's what investors should know. Altria missed analysts' revenue expectations by 2.5% last quarter, reporting revenues of $4.52 billion, down 4.2% year on year. It was a mixed quarter for the company, with a decent beat of analysts' EBITDA estimates but a significant miss of analysts' gross margin estimates. Is Altria a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Altria's revenue to decline 1.5% year on year to $5.20 billion, improving from the 3% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.38 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Altria has missed Wall Street's revenue estimates six times over the last two years. Looking at Altria's peers in the beverages, alcohol, and tobacco segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Boston Beer delivered year-on-year revenue growth of 1.5%, meeting analysts' expectations, and Coca-Cola reported revenues up 2.1%, topping estimates by 0.5%. Boston Beer traded up 6.5% following the results while Coca-Cola was down 1.4%. Read our full analysis of Boston Beer's results here and Coca-Cola's results here. There has been positive sentiment among investors in the beverages, alcohol, and tobacco segment, with share prices up 3.8% on average over the last month. Altria's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $58.54 (compared to the current share price of $58.94). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Yahoo
a day ago
- Business
- Yahoo
Altria (MO) Reports Q2: Everything You Need To Know Ahead Of Earnings
Tobacco company Altria (NYSE:MO) will be reporting results this Wednesday before market hours. Here's what investors should know. Altria missed analysts' revenue expectations by 2.5% last quarter, reporting revenues of $4.52 billion, down 4.2% year on year. It was a mixed quarter for the company, with a decent beat of analysts' EBITDA estimates but a significant miss of analysts' gross margin estimates. Is Altria a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Altria's revenue to decline 1.5% year on year to $5.20 billion, improving from the 3% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.38 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Altria has missed Wall Street's revenue estimates six times over the last two years. Looking at Altria's peers in the beverages, alcohol, and tobacco segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Boston Beer delivered year-on-year revenue growth of 1.5%, meeting analysts' expectations, and Coca-Cola reported revenues up 2.1%, topping estimates by 0.5%. Boston Beer traded up 6.5% following the results while Coca-Cola was down 1.4%. Read our full analysis of Boston Beer's results here and Coca-Cola's results here. There has been positive sentiment among investors in the beverages, alcohol, and tobacco segment, with share prices up 3.8% on average over the last month. Altria's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $58.54 (compared to the current share price of $58.94). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Yahoo
4 days ago
- Business
- Yahoo
Here's Why Altria (MO) is a Strong Growth Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics. Why This 1 Growth Stock Should Be On Your Watchlist For growth investors, a company's financial strength, overall health, and future outlook take precedence, so they'll want to zero in on the Growth Style Score. This Score examines things like projected and historical earnings, sales, and cash flow to find stocks that will generate sustainable growth over time. Altria (MO) Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. MO sits at a Zacks Rank #3 (Hold), holds a Growth Style Score of B, and has a VGM Score of B. Earnings and sales are forecasted to increase 4.9% and 1.5% year-over-year, respectively. Two analysts revised their earnings estimate higher in the last 60 days for fiscal 2025, while the Zacks Consensus Estimate has increased $0.02 to $5.37 per share. MO also boasts an average earnings surprise of 1.3%. On a historic basis, Altria has generated cash flow growth of 2.3%, and is expected to report cash flow expansion of 0.3% this year. With solid fundamentals, a good Zacks Rank, and top-tier Growth and VGM Style Scores, MO should be on investors' short lists. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Altria Group, Inc. (MO) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
22-07-2025
- Business
- Yahoo
The FDA Just Approved Juul's E-Cigarettes. Does That Make Altria Stock a Buy Here?
Following a prolonged and high-stakes legal battle, the U.S. Food and Drug Administration (FDA) granted Juul marketing approval for its e-cigarettes. For Altria (MO), a tobacco giant and an early investor in Juul, this is an interesting development. While this is a positive on the regulatory front for the wider e-cigarette industry in general and the company's own NJOY brand, it also raises competitive pressure for Altria in the vaping market as it no longer holds a position in Juul. Investors should note that at the end of March, Altria also announced that it would halt sales of its NJOY e-cigarettes in the U.S. due to a patent infringement ruling in favor of Juul. More News from Barchart Opendoor Stock Is Surging Higher in a Frenzied Retail Rally. How Should You Play OPEN Shares Here? This Penny Stock Wants to Become the MicroStrategy of Dogecoin Robinhood Stock Stumbles as S&P 500 Inclusion Is Once Again Off the Table for HOOD Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! About Altria Altria is one of the most popular tobacco companies in the world with iconic brand such as Marlboro, Copenhagen, Skoal, and Black & Mild in its portfolio. Its diversified presence also includes smokeless products, cigars, and nicotine alternatives such as the aforementioned NJOY. MO stock is up 13.4% on a YTD basis, with the company boasting a market cap of $99 billion. Tobacco stocks are known for having high dividend yields, but Altria's is especially high at 6.9%. Moreover, the company is a 'Dividend King,' having increased dividends consecutively over the past 54 years. So, how should one play MO stock now? Let's have a closer look. Boring But Steady Financials When it comes to Altria's numbers, they are nothing extraordinary. In fact, they are quite boring, marked by not much growth. Over the past 10 years, the company's revenue and earnings have reported CAGRs of just -0.4% and 8%, respectively. Following this trend, the first quarter was a mixed bag for the company. While net revenues of $5.5 billion denoted a yearly decline of 5.7%, adjusted earnings went up by 6% in the same period to $1.23. A decline of 13.3% seen in shipments of its flagship Marlboro cigarettes was a primary reason for the overall decline in sales. Meanwhile, while volumes for NJOY consumables increased by 23.9% from the previous year to 13.5 million units, NJOY devices witnessed a significant 70% decline in reported shipments. Overall, its retail share of consumables increased to 6.6%. Altria closed the quarter with a cash balance of $4.73 billion. This was above its short-term debt levels of $2.6 billion. For 2025, the company expects its earnings to be in the range of $5.30 to $5.45 per share, the midpoint of which would represent growth of 5% from 2024. Altria's Tailwinds and Headwinds One growth product for Altria is its On! nicotine pouch brand, which has been gaining ground, and could take the lead in place of NJOY in its alternative portfolio. The company grew the market share of its On! pouches to 8.8%, up from 7% in the year-ago period. Sales volumes also grew to 39.3 million cans, a jump of 18% from a year ago. Notably, the company sees potential for further expansion, especially with new flavors planned and the possibility of launching On! PLUS in the U.S., a variant currently sold in select European markets. Further, despite shifting industry trends, Altria's cigarette business remains strong. Marlboro still holds nearly 46% of the U.S. cigarette market, maintaining its dominance. Additionally, the Black & Mild brand also continues to perform well in the machine-made cigar category. Meanwhile, on the heated tobacco front, often referred to as HTC, Altria is exploring two new products: Ploom and SWIC. Both are marketed as reduced-risk alternatives. Ploom, a product developed with Japan Tobacco, is awaiting FDA authorization before a potential U.S. debut. While timelines aren't certain, Altria seems optimistic. The other option, SWIC, features a capsule-style heated tobacco system and might appeal to smokers who haven't transitioned to vape products but are still looking for non-combustible alternatives. That said, not all bets have worked out. The $12.8 billion investment in Juul Labs failed to pan out, and Altria eventually abandoned that stake. Perhaps even more problematic was losing the right to sell IQOS in the U.S., a product many had viewed as a cornerstone of its reduced-risk portfolio. Though On! is gaining, the broader picture in oral tobacco tells a different story. Altria's overall share in the segment slipped from 37.8% to 34.7% year-over-year. Meanwhile, the NJOY ACE platform is in limbo. The U.S. International Trade Commission issued cease-and-desist and exclusion orders, preventing Altria from importing or selling it domestically for now. This followed a ruling that NJOY ACE had infringed on four Juul Labs patents. Altria could try modifying the device to bypass those patents, but that approach may be risky. Any major redesign would likely trigger a fresh FDA application, and the approval process is neither quick nor guaranteed. Analyst Opinions on MO Stock Thus, analysts have deemed MO stock to be a 'Hold' with a mean target price of $57.73, which has already been surpassed. However, the high target price of $65 denotes an upside potential of about 8% from current levels. Out of 14 analysts covering the stock, four have a 'Strong Buy' rating, eight have a 'Hold' rating, one has a 'Moderate Sell' rating, and one has a 'Strong Sell' rating. On the date of publication, Pathikrit Bose did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
